3-氨基-4-氰基吡唑
3-氨基-4-氰基吡唑结构式
|
常用名 | 3-氨基-4-氰基吡唑 | 英文名 | 3-Amino-4-cyanopyrazole |
|---|---|---|---|---|
| CAS号 | 16617-46-2 | 分子量 | 108.10 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 476.4±30.0 °C at 760 mmHg | |
| 分子式 | C4H4N4 | 熔点 | 172-174 °C(lit.) | |
| MSDS | 中文版 美版 | 闪点 | 241.9±24.6 °C |
|
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.
Mol. Cell. Endocrinol. 393(1-2) , 56-64, (2014) CLM29 (a pyrazolo[3,4-d]pyrimidine, that inhibits RET, epidermal growth factor receptor, vascular endothelial growth factor receptor, and has an anti-angiogenic activity) has anti-neoplastic activity in papillary dedifferentiated thyroid cancer. Here we teste... |
|
|
Synlett , 65, (2006)
|
|
|
Helv. Chim. Acta 89 , 30, (2006)
|
|
|
Impurity profile study of zaleplon.
J. Pharm. Biomed. Anal. 44(1) , 101-9, (2007) Zaleplon is a pyrazolopyrimidine derivative and possesses sedative and hypnotic properties. Seven unknown impurities in zaleplon bulk drug at levels below 0.1% were detected by reverse-phase high performance liquid chromatography (HPLC). The starting material... |